The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.

Bibliográfalaš dieđut
Váldodahkki:	Feldmann, M
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1996

Geahča maid

TNF alpha as a therapeutic target in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1994)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1995)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1994)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1994)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2002)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
Dahkki: Brennan, F, et al.
Almmustuhtton: (1992)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1995)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
Dahkki: Maini, R, et al.
Almmustuhtton: (1993)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2001)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2003)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
Dahkki: Charles, P, et al.
Almmustuhtton: (1999)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2002)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2001)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
Dahkki: Elliott, M, et al.
Almmustuhtton: (1995)

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2008)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Dahkki: Maini, R, et al.
Almmustuhtton: (1995)

Development of anti-TNF therapy for rheumatoid arthritis.
Dahkki: Feldmann, M
Almmustuhtton: (2002)

Cytokine therapy in rheumatoid arthritis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1996)

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2003)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
Dahkki: Taylor, P, et al.
Almmustuhtton: (2004)

Molecular therapeutic targets in rheumatoid arthritis.
Dahkki: Sacre, S, et al.
Almmustuhtton: (2005)

Role of cytokines in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1996)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2011)

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.
Dahkki: Brennan, F, et al.
Almmustuhtton: (1989)

The role of cytokines in the pathogenesis of rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (1999)

Cytokine expression in rheumatoid arthritis.
Dahkki: Brennan, F, et al.
Almmustuhtton: (1991)

TNFα - A pivotal role in rheumatoid arthritis?
Dahkki: Brennan, F, et al.
Almmustuhtton: (1992)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
Dahkki: Alessia Alunno, et al.
Almmustuhtton: (2017-11-01)

Cytokine blockade in rheumatoid arthritis.
Dahkki: Feldmann, M, et al.
Almmustuhtton: (2001)

Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Dahkki: Foey, A, et al.
Almmustuhtton: (2003)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
Dahkki: Maini, R, et al.
Almmustuhtton: (1997)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
Dahkki: Brennan, F, et al.
Almmustuhtton: (1998)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
Dahkki: Taylor, P, et al.
Almmustuhtton: (2000)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
Dahkki: Taylor, P, et al.
Almmustuhtton: (2009)

TNF as a therapeutic target
Dahkki: Bondeson, J, et al.
Almmustuhtton: (2000)

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Dahkki: Williams, R, et al.
Almmustuhtton: (2007)

Quercetin, a Compound of the Total Flavonoids of Periploca forrestii Schltr., Ameliorates Rheumatoid Arthritis by Targeting TNF-α
Dahkki: Chen S, et al.
Almmustuhtton: (2025-02-01)

Cerebral processing of pain in rheumatoid arthritis patients treated with antiTNF-alpha
Dahkki: Wartolowska, K, et al.
Almmustuhtton: (2008)

The TNF/TNF-R family: A gold mine for clinical therapeutic targets?
Dahkki: Feldmann, M
Almmustuhtton: (2011)